W-Scope Chungju Plant (A393890) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Feb, 2026Executive summary
Revenue in 2Q25 rose to KRW 38.2bn, up 134% sequentially from 1Q25 but down 67% year-over-year from 2Q24.
Operating and net losses narrowed compared to 1Q25, reflecting improved utilization and cost controls.
Demand recovery in small mobility, PT, wearable, and EU EV batteries contributed to revenue growth.
Financial highlights
Gross profit in 2Q25 was -KRW 23.0bn (-60.2% margin), an improvement from -KRW 26.5bn in 1Q25.
Operating loss in 2Q25 was -KRW 26.0bn (-68.1% margin), better than -KRW 30.4bn in 1Q25.
Net loss in 2Q25 was -KRW 28.0bn (-73.3% margin), improved from -KRW 31.2bn in 1Q25.
EBITDA in 2Q25 was -KRW 11.6bn (-30.4% margin), up from -KRW 16.1bn in 1Q25.
CAPEX in 2Q25 was KRW 104.8bn, down from KRW 142.2bn in 1Q25.
Outlook and guidance
Stronger growth expected in 2H25, with rising demand for both small and large battery products.
Operating losses projected to narrow further as utilization rates increase and cost structures are optimized.
Mid- to long-term goal to reach KRW 1tn in revenue and a fivefold sales volume increase over five years.
Over 60% of revenue targeted from the North American market; Ion Exchange Membrane business identified as a future growth engine.
Latest events from W-Scope Chungju Plant
- Revenue up year-over-year, but profit and margins fell; prismatic battery demand remains strong.A393890
Q2 202420 Feb 2026 - Sharp revenue drop and negative profits amid rising debt and weak demand.A393890
Q3 202420 Feb 2026 - Severe revenue and profit declines in 4Q24, with rising debt and negative margins.A393890
Q4 202420 Feb 2026 - Severe revenue and profit declines in 1Q25, but global expansion and new orders targeted.A393890
Q1 202520 Feb 2026 - 3Q25 saw steep revenue decline, deeper losses, and higher debt amid ongoing margin pressure.A393890
Q3 202520 Feb 2026 - Losses continued in 4Q25 despite revenue recovery, with cost and utilization challenges persisting.A393890
Q4 202520 Feb 2026